RU2722441C2 - Замещённые индольные соединения в качестве понижающих регуляторов рецепторов эстрогена - Google Patents
Замещённые индольные соединения в качестве понижающих регуляторов рецепторов эстрогена Download PDFInfo
- Publication number
- RU2722441C2 RU2722441C2 RU2018135203A RU2018135203A RU2722441C2 RU 2722441 C2 RU2722441 C2 RU 2722441C2 RU 2018135203 A RU2018135203 A RU 2018135203A RU 2018135203 A RU2018135203 A RU 2018135203A RU 2722441 C2 RU2722441 C2 RU 2722441C2
- Authority
- RU
- Russia
- Prior art keywords
- equiv
- compound
- μmol
- mmol
- reaction solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610180518 | 2016-03-25 | ||
| CN201610180518.7 | 2016-03-25 | ||
| CN201610867918.5 | 2016-09-29 | ||
| CN201610867918 | 2016-09-29 | ||
| PCT/CN2017/078139 WO2017162206A1 (zh) | 2016-03-25 | 2017-03-24 | 作为雌激素受体降解剂的吲哚并取代哌啶类化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018135203A3 RU2018135203A3 (cg-RX-API-DMAC10.html) | 2020-04-27 |
| RU2018135203A RU2018135203A (ru) | 2020-04-27 |
| RU2722441C2 true RU2722441C2 (ru) | 2020-06-01 |
Family
ID=59899253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018135203A RU2722441C2 (ru) | 2016-03-25 | 2017-03-24 | Замещённые индольные соединения в качестве понижающих регуляторов рецепторов эстрогена |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10519143B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3434668B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP6790222B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR102111792B1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN108884035B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2017239348B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3018801C (cg-RX-API-DMAC10.html) |
| ES (1) | ES2821407T3 (cg-RX-API-DMAC10.html) |
| RU (1) | RU2722441C2 (cg-RX-API-DMAC10.html) |
| SG (1) | SG11201808363TA (cg-RX-API-DMAC10.html) |
| WO (1) | WO2017162206A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111032627B (zh) | 2017-09-25 | 2023-10-20 | 罗欣健康科技发展(北京)有限公司 | 一种雌激素受体抑制剂的晶型及其制备方法 |
| AU2019321588C1 (en) | 2018-08-17 | 2026-05-14 | Genentech, Inc. | Diagnostic and therapeutic methods for the treatment of breast cancer |
| EP3889136B1 (en) * | 2018-11-28 | 2024-12-18 | Luoxin Pharmaceutical (Shanghai) Co., Ltd. | Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor |
| AU2019400398B2 (en) * | 2018-12-17 | 2024-10-03 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Estrogen receptor antagonist |
| CN116891461B (zh) * | 2022-03-30 | 2026-05-15 | 罗欣药业(上海)有限公司 | 一种serd中间体的合成方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA000815B1 (ru) * | 1996-04-19 | 2000-04-24 | Американ Хоум Продактс Корпорейшн | Производные индола в качестве эстрогенных агентов |
| WO2012037411A2 (en) * | 2010-09-16 | 2012-03-22 | Aragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
| WO2015136017A1 (en) * | 2014-03-13 | 2015-09-17 | F. Hoffmann-La Roche Ag | Methods and compositions for modulating estrogen receptor mutants |
| WO2015136016A2 (en) * | 2014-03-13 | 2015-09-17 | F. Hoffmann-La Roche Ag | Therapeutic combinations with estrogen receptor modulators |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100317635A1 (en) * | 2009-06-16 | 2010-12-16 | Endorecherche, Inc. | Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
| GB0917571D0 (en) | 2009-10-07 | 2009-11-25 | Karobio Ab | Novel estrogen receptor ligands |
| US9499538B2 (en) * | 2012-03-20 | 2016-11-22 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
-
2017
- 2017-03-24 WO PCT/CN2017/078139 patent/WO2017162206A1/zh not_active Ceased
- 2017-03-24 EP EP17769483.3A patent/EP3434668B1/en active Active
- 2017-03-24 SG SG11201808363TA patent/SG11201808363TA/en unknown
- 2017-03-24 RU RU2018135203A patent/RU2722441C2/ru active
- 2017-03-24 ES ES17769483T patent/ES2821407T3/es active Active
- 2017-03-24 KR KR1020187030877A patent/KR102111792B1/ko active Active
- 2017-03-24 US US16/087,861 patent/US10519143B2/en active Active
- 2017-03-24 CN CN201780019970.8A patent/CN108884035B/zh active Active
- 2017-03-24 CA CA3018801A patent/CA3018801C/en active Active
- 2017-03-24 AU AU2017239348A patent/AU2017239348B2/en active Active
- 2017-03-24 JP JP2019500726A patent/JP6790222B2/ja active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA000815B1 (ru) * | 1996-04-19 | 2000-04-24 | Американ Хоум Продактс Корпорейшн | Производные индола в качестве эстрогенных агентов |
| WO2012037411A2 (en) * | 2010-09-16 | 2012-03-22 | Aragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
| WO2015136017A1 (en) * | 2014-03-13 | 2015-09-17 | F. Hoffmann-La Roche Ag | Methods and compositions for modulating estrogen receptor mutants |
| WO2015136016A2 (en) * | 2014-03-13 | 2015-09-17 | F. Hoffmann-La Roche Ag | Therapeutic combinations with estrogen receptor modulators |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3018801A1 (en) | 2017-09-28 |
| RU2018135203A3 (cg-RX-API-DMAC10.html) | 2020-04-27 |
| CN108884035A (zh) | 2018-11-23 |
| US20190106414A1 (en) | 2019-04-11 |
| ES2821407T3 (es) | 2021-04-26 |
| SG11201808363TA (en) | 2018-10-30 |
| US10519143B2 (en) | 2019-12-31 |
| EP3434668B1 (en) | 2020-08-26 |
| RU2018135203A (ru) | 2020-04-27 |
| EP3434668A4 (en) | 2019-08-14 |
| ES2821407T8 (es) | 2022-02-02 |
| CN108884035B (zh) | 2020-03-13 |
| WO2017162206A1 (zh) | 2017-09-28 |
| EP3434668A1 (en) | 2019-01-30 |
| KR102111792B1 (ko) | 2020-05-18 |
| AU2017239348B2 (en) | 2020-03-12 |
| JP2019512550A (ja) | 2019-05-16 |
| JP6790222B2 (ja) | 2020-11-25 |
| CA3018801C (en) | 2020-06-23 |
| KR20180128456A (ko) | 2018-12-03 |
| HK1256936A1 (zh) | 2019-10-04 |
| AU2017239348A1 (en) | 2018-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7266538B2 (ja) | Fxr受容体作動薬としてのラクタム系化合物 | |
| WO2019085933A1 (zh) | 作为Wee1抑制剂的大环类化合物及其应用 | |
| TWI250152B (en) | N,N-substituted cyclic amine compounds used as calcium antagonizer | |
| RU2727705C1 (ru) | Производное бензопиперидина, способ его получения и его медицинское применение | |
| CN110139863B (zh) | 作为雌激素受体降解剂的吲哚并取代哌啶类化合物 | |
| TWI714566B (zh) | 軸手性異構體及其製備方法和製藥用途 | |
| KR100250922B1 (ko) | 교감신경 흥분 및 항빈뇨 활성을 갖는 에탄올아민 유도체 | |
| JP7237010B2 (ja) | Hdac6選択的阻害剤およびその製造方法と使用 | |
| AU2017251555B2 (en) | Pyridone derivative comprising heteroatomic ring butane substituent, for treating fibrosis and inflammatory diseases | |
| JP6790222B2 (ja) | エストロゲン受容体ダウンレギュレーターとしての置換インドール化合物 | |
| TW201625533A (zh) | Kcnq 2至5通道活化劑 | |
| CN113896669B (zh) | 雌激素受体调节剂及其用途 | |
| WO2019134662A1 (zh) | 作为csf-1r抑制剂的杂环化合物及其应用 | |
| JP3231775B2 (ja) | 心循環器系に作用する2−アミノ−1,2,3,4−テトラヒドロナフタレン誘導体、それらを製造する方法、及びそれらを含む医薬組成物 | |
| JP2010512339A (ja) | Ampa受容体増強剤 | |
| CN107428682B (zh) | 酰胺类衍生物、其制备方法及其在医药上的用途 | |
| JP7716980B2 (ja) | エストロゲン受容体拮抗剤 | |
| WO2023280295A1 (zh) | 一类苯并七元环类化合物及其应用 | |
| EP4508028B1 (en) | Novel substituted 4-amino-4-oxo-but-2-enyl derivatives, processes for their preparation and therapeutic uses thereof | |
| WO2019120198A1 (zh) | 一类喹啉衍生物 | |
| CN120202198A (zh) | 一种具有软药性质的硫醚类化合物、药物组合物及其用途 | |
| RU2772274C2 (ru) | Селективные ингибиторы hdac6, способ их получения и их применение | |
| BRPI0806888A2 (pt) | Derivados de benzoquinazolina | |
| HK1256936B (en) | Substituted-indole compounds as estrogen receptor down-regulators | |
| TW202440081A (zh) | σ-1受體拮抗劑及其應用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC41 | Official registration of the transfer of exclusive right |
Effective date: 20220209 |